nach oben

Clinical and Translational Oncology

Erschienen in:

01.06.2015 | Correspondence

Current radiation therapy techniques for lung cancer and its importance for suitable radiological assessment of treatment response in lung cancer

verfasst von: J. J. Cabrera Rodríguez

Erschienen in: Clinical and Translational Oncology | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor: …

De Castro J, Cobo M, Isla D, Puente J, Reguart N, Cabeza M, et al. Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology. Clin Transl Oncol. 2015;17:17–23.CrossRef

Vansteenkiste J, De Ruysscher D, Eberhardt WEE, Lim E, Senan S, Felpip E, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi89–98.

NCCN clinical practice guidelines in oncology (NCCN Guidelines^®) Non-small cell lung cancer. Version 4. 2015. http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed March 2015.

Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of Stage I and II non-small cell lung cancer. Diagnosis and management of lung cancer, 3^rd edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2013;143:e278S–313S.CrossRefPubMed

Timmermans RD, Herman J, Chao LC. Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice. J Clin Oncol. 2014;32:2847–54.CrossRef

Corso CD, Park HS, Moreno AC, Kim AW, Yu JB. Husain ZA, et al. Stage I lung SBRT clinical practice patterns. Am J Clin Oncol. 2014 [Epub ahead of print].

Huang K, Dahele M, Senan S, Guckenberger M, Rodrigues GB, Ward A, et al. Radiographic changes after lung stereotactic ablative radiotherapy (SABR)—can we distinguish recurrence from fibrosis? A systematic review of the literature. Radiother Oncol. 2012;102:335–42.CrossRefPubMed

Huang K, Senthi S, Palma DA, Spoelstra FOB, Warner A, Slotman BJ, et al. High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer. Radiother Oncol. 2013;103:51–7.CrossRef

Huang K, Palma DA. Follow-up of patients after stereotactic radiation for lung cancer. a primer for the nonradiation oncologist. J Thorac Oncol. 2015;10:412–9.CrossRefPubMed

10.

Jiang Z-Q, Yang K, Komaki R, Wei X, Tucker SL, Zhuang Y, et al. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience. Int J Radiat Oncol Biol Phys. 2012;83:332–9.CrossRefPubMed

11.

Sura S, Gupta V, Yorke E, Jackson A, Amols H, Rosenzweig KE. Intensity-modulated radiation therapy for inoperable non-small cell lung cancer: The Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Radiother Oncol. 2008;87:17–23.CrossRefPubMedCentralPubMed

12.

Van Baardwijk A, Reymen B, Wanders S, Borger J, Öllers M, Dingemans A-MC, et al. Mature results of a phase II trial on individualized accelerated radiotherapy based on normal tissue constrains in concurrent chemo-irradiation for Stage III non-small cell lung cancer. Eur J Cancer. 2012;48:2339–46.CrossRefPubMed

13.

Ji K, Zhao LJ, Liu WS, Liu ZY, Yuan ZY, Pang QS, Wang J, et al. Simultaneous integrated boost intensity-modulated radiotherapy for treatment of locally advanced non-small-cell lung cancer: a retrospective clinical study. Br J Radiol. 2014;87:20130562.CrossRefPubMedCentralPubMed

14.

Han D, Qin Q, Hao S, Huang W, Wei Y, Zhang Z, et al. Feasibility and efficacy of simultaneous integrated boost intensity-modulated radiation therapy in patients with limited-disease small cell lung cancer. Radiat Oncol. 2014;9:280.CrossRefPubMedCentralPubMed

Titel: Current radiation therapy techniques for lung cancer and its importance for suitable radiological assessment of treatment response in lung cancer
verfasst von: J. J. Cabrera Rodríguez
Publikationsdatum: 01.06.2015
Verlag: Springer Milan
Erschienen in: Clinical and Translational Oncology / Ausgabe 6/2015
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-015-1286-y

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Current radiation therapy techniques for lung cancer and its importance for suitable radiological assessment of treatment response in lung cancer

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2015

The clinical pathological significance of FRAT1 and ROR2 expression in cartilage tumors

CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo

Impairment of vascularization of the surface covering epithelium induces ischemia and promotes malignization: a new hypothesis of a possible mechanism of cancer pathogenesis

Clinical radiobiology of head and neck cancer: the hypothesis of stem cell activation

A new tumor biomarker, serum protein peak at 3,144 m/z, in patients with node-positive breast cancer

Involvement of RalB in the effect of geranylgeranyltransferase I on glioma cell migration and invasion

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie